Mr. Speaker, I thank the hon. member for the question. Obviously the hon. member does not have all of the facts.
The hon. member should be aware that in previous years the amount of the contract awarded to the company from the province of Quebec was approximately 38 per cent over a three year average.
This year because of the representations made by the hon. member and her party, all of which we took into consideration, we were able to have an agreement in principle where both parties, Connaught industries from Ontario and BioVac from Quebec, would be able to split a contract on a 50:50 basis. Keep in mind that the Government of Canada purchased less than 1 per cent of the vaccine and 99 per cent of that particular contract was purchased by the other provinces across this country.